Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2012 (2012), Article ID 149780, 11 pages
http://dx.doi.org/10.1155/2012/149780
Research Article

EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma

1Department Human Pathology and Oncology, University of Siena, 53100 Siena, Italy
2Department of Oncology, Hematology, University of Siena, 53100 Siena, Italy
3Pilgrims' Hospice, Margate, Kent CT94AD, UK
4Department Biotechnology, Section of Microbiology, University of Siena, 53100 Siena, Italy

Received 12 October 2011; Revised 10 February 2012; Accepted 12 February 2012

Academic Editor: Kikkeri N. Naresh

Copyright © 2012 Susanna Mannucci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Leoncini, M. Raphael, H. Stein et al., WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues, IARC Press, Lyon, France, 2008.
  2. D. Burkitt, “A sarcoma involving the jaws in African children,” British Journal of Surgery, vol. 46, no. 197, pp. 218–223, 1958. View at Google Scholar
  3. C. A. van den Bosch, “Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter?” Lancet Oncology, vol. 5, no. 12, pp. 738–746, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Leucci, M. Cocco, A. Onnis et al., “MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation,” Journal of Pathology, vol. 216, no. 4, pp. 440–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Leucci, A. Onnis, M. Cocco et al., “B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression,” International Journal of Cancer, vol. 126, no. 6, pp. 1316–1326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Epstein, “The origins of EBV research discovery and characterization of the virus,” in Epstein-Barr Virus, E. S. Robinson, Ed., chapter 1, pp. 1–14, Caister Academic Press, Norfolk, UK, 2005. View at Google Scholar
  7. G. M. Lenoir, J. L. Preud'homme, A. Bernheim, and R. Berger, “Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma,” Nature, vol. 298, no. 5873, pp. 474–476, 1982. View at Google Scholar · View at Scopus
  8. H. H. Niller, D. Salamon, K. Ilg et al., “The in vivo binding site for oncoprotein c-MYC in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis,” Medical Science Monitor, vol. 9, no. 1, pp. HY1–HY9, 2003. View at Google Scholar · View at Scopus
  9. A. M. Moormann, K. Chelimo, O. P. Sumba et al., “Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children,” Journal of Infectious Diseases, vol. 191, no. 8, pp. 1233–1238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Magrath, V. Jain, and K. Bhatia, “Epstein-Barr virus and Burkitt's lymphoma,” Seminars in Cancer Biology, vol. 3, no. 5, pp. 285–295, 1992. View at Google Scholar · View at Scopus
  11. G. de Thé, “Epstein-Barr virus and Burkitt's lymphoma worldwide: the casual relationship revisited,” in A Human Cancer Model, Burkitt's Lymphoma, G. Lenoir, G. O’Conor, and C. L. M. Olweny, Eds., pp. 165–175, IARC Scientific Publication No. 60, Lyon, France, 1985. View at Google Scholar
  12. G. de Thé, “Epstein_Barr virus and associated diseases. Course of medical virology, institut pasteur, 1995-6,” Annales de Médecine Interne (Paris), vol. 148, pp. 357–366, 1997. View at Google Scholar
  13. G. de Thé, A. Geser, and N. E. Day, “Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study,” Nature, vol. 274, no. 5673, pp. 756–761, 1978. View at Google Scholar · View at Scopus
  14. P. H. Levine, J. F. Fraumeni, J. I. Reisher, and D. E. Waggoner, “Antibodies to Epstein Barr virus associated antigens in relatives of cancer patients,” Journal of the National Cancer Institute, vol. 52, no. 4, pp. 1037–1040, 1974. View at Google Scholar · View at Scopus
  15. A. Hildesheim, S. West, E. DeVeyra et al., “Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma,” Cancer Research, vol. 52, no. 11, pp. 3048–3051, 1992. View at Google Scholar · View at Scopus
  16. Y. Ito, “Vegetable Activators of the viral genome and the Causations of Burkitt's lymphoma and Nasopharyngeal carcinoma,” in The Epstein-Barr Virus: Recent Advances, M. A. Epstein and B. G. Achong, Eds., chapter 8, pp. 207–237, William Heinemann Medical Books, London, UK, 1985. View at Google Scholar
  17. C. van den Bosch, B. E. Griffin, P. Kazembe, C. Dziweni, and L. Kadzamira, “Are plant factors a missing link in the evolution of endemic Burkitt's Lymphoma?” British Journal of Cancer, vol. 68, no. 6, pp. 1232–1235, 1993. View at Google Scholar · View at Scopus
  18. T. Osato, S. Imai, and S. Koizumi, “African Burkitt's lymphoma and an Epstein-Barr virus-enhancing plant Euphorbia triucalli,” The Lancet, vol. 1, no. 8544, pp. 1257–1258, 1987. View at Google Scholar · View at Scopus
  19. T. Osato, “Epstein-Barr virus infection and oncogenesis,” in Epstein-Barr Virus and Human Cancer. Gann Monograph on Cancer Research no. 45, pp. 7–11, Japanese Cancer Association. Japan Scientific Societies Press, Tokyo, Japan, Karger, Basel, Switzerland, 1998. View at Google Scholar
  20. G. Furstenberger and E. Hecker, “On the active principles of the spurge family (Euphorbiaceae). XI. [1] The skin irritant and tumor promoting diterpene esters of Euphorbia tirucalli L. originating from South Africa,” Zeitschrift fur Naturforschung C, vol. 40, no. 9-10, pp. 631–646, 1985. View at Google Scholar · View at Scopus
  21. F. Mizuno, S. Koizumi, and T. Osato, “Chinese and African Euphorbiaceae plant extracts: markedly enhancing effect on Epstein-Barr virus-induced transformation,” Cancer Letters, vol. 19, no. 2, pp. 199–205, 1983. View at Google Scholar · View at Scopus
  22. A. MacNeil, O. P. Sumba, M. L. Lutzke, A. Moormann, and R. Rochford, “Activation of the Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli,” British Journal of Cancer, vol. 88, no. 10, pp. 1566–1569, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Imai, M. Sugiura, F. Mizuno et al., “African Burkitt's lymphoma: a plant, Euphorbia tirucalli reduces Epstein-Barr virus-specific cellular immunity,” Anticancer Research, vol. 14, no. 3, pp. 933–936, 1994. View at Google Scholar · View at Scopus
  24. M. Kanamori, M. Tajima, Y. Satoh et al., “Differential effect of TPA on cell growth and Epstein-Barr virus reactivation in epithelial cell lines derived from gastric tissues and B cell line Raji,” Virus Genes, vol. 20, no. 2, pp. 117–125, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. H. D. Neuwinger, “Euphorbia tirucalli,” in African Ethnobotany: Poisons and Drugs. Chemistry, Pharmacology, Toxicology, pp. 456–461, Chapman and Hall, Pub Weinheim, Germany, 1996. View at Google Scholar
  26. A. H. Davies, R. J. A. Grand, F. J. Evans, and A. B. Rickinson, “Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C,” Journal of Virology, vol. 65, no. 12, pp. 6838–6844, 1991. View at Google Scholar · View at Scopus
  27. T. Aya, T. Kinoshita, S. Imai et al., “Chromosome translocation and c-MYC activation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes,” The Lancet, vol. 337, no. 8751, p. 1190, 1991. View at Publisher · View at Google Scholar · View at Scopus
  28. C. M. Steel, J. E. Morten, and E. Foster, “The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines,” IARC Scientific Publications, no. 60, pp. 265–292, 1985. View at Google Scholar · View at Scopus
  29. F. Pelloquin, J. P. Lamelin, and G. M. Lenoir, “Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A,” In Vitro Cellular and Developmental Biology, vol. 22, no. 12, pp. 689–694, 1986. View at Google Scholar · View at Scopus
  30. Y. Ito, M. Kawanishi, T. Harayama, and S. Takabayashi, “Combined effect of the extracts from Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli and n-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells,” Cancer Letters, vol. 12, no. 3, pp. 175–180, 1981. View at Google Scholar · View at Scopus
  31. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. D. A. Thorley-Lawson and A. Gross, “Persistence of the Epstein-Barr Virus and the Origins of Associated Lymphomas,” New England Journal of Medicine, vol. 350, no. 13, pp. 1328–1337, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. C. H. Hsu, M. Hergenhahn, S. E. Chuang et al., “Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin,” Anticancer Research, vol. 22, no. 6, pp. 4065–4071, 2002. View at Google Scholar · View at Scopus
  34. D. S. Llanes-Coronel, L. Y. Gámez-Díaz, L. P. Suarez-Quintero et al., “New promising Euphorbiaceae extracts with activity in human lymphocytes from primary cell cultures,” Immunopharmacology and Immunotoxicology, vol. 33, no. 2, pp. 279–290, 2011. View at Publisher · View at Google Scholar
  35. C. D. Laherty, Hong Ming Hu, A. W. Opipari, F. Wang, and V. M. Dixit, “The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor κB,” Journal of Biological Chemistry, vol. 267, no. 34, pp. 24157–24160, 1992. View at Google Scholar · View at Scopus
  36. A. de Leo, G. Arena, C. Stecca, M. Raciti, and E. Mattia, “Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program,” Molecular Cancer Research, vol. 9, no. 10, pp. 1346–1355, 2011. View at Publisher · View at Google Scholar
  37. O. Anna, D. F. Giulia, B. Cristiana, M. Federica, R. Emily, and L. Lorenzo, “MicroRNA expression profile identifies a different signature between MYC translocation-positive and negative Burkitt Lymphoma cases. New insights into the miRNA regulation relied on MYC pseudogene expression”.
  38. C. Kaiser, G. Laux, D. Eick, N. Jochner, G. W. Bornkamm, and B. Kempkes, “The proto-oncogene c-MYC is a direct target gene of Epstein-Barr virus nuclear antigen 2,” Journal of Virology, vol. 73, no. 5, pp. 4481–4484, 1999. View at Google Scholar · View at Scopus
  39. S. Henderson, M. Rowe, C. Gregory et al., “Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death,” Cell, vol. 65, no. 7, pp. 1107–1115, 1991. View at Google Scholar · View at Scopus